Aat Bioquest

EDANS acid [5-((2-Aminoethyl)amino)naphthalene-1-sulfonic acid] *CAS 50402-56-7*

610 1 g
EUR 158.4

Aat Bioquest Laboratories manufactures the aat bioquest reagents distributed by Genprice. The Aat Bioquest reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact AAT Bioquest. Other Aat products are available in stock. Specificity: Aat Category: Bioquest

bBBr [Dibromobimane] *CAS 68654-25-1*

5 mg
EUR 138

5-OG488 acid [equivalent to Oregon Green® 488 carboxylic acid, 5-isomer]

25 mg
EUR 262.8

FMOC-Asp(DABCYL)-OH

100 mg
EUR 367.2

FMOC-Asp(TQ2)-OH

100 mg
EUR 471.6

FMOC-Asp(TQ3)-OH

100 mg
EUR 471.6

FMOC-Glu(DABCYL)-OH

100 mg
EUR 367.2

FMOC-Glu(TQ2)-OH

100 mg
EUR 471.6

Serum / Plasma information

APC-AAT complex antibody

10-1738 200 ul
EUR 651.6
Description: Mouse monoclonal APC-AAT complex antibody

AAT Polyclonal Conjugated Antibody

C41927 100ul
EUR 476.4

Alpha-1-Antitrypsin (AAT) Antibody

abx010340-100ul 100 ul
EUR 493.2

Monoclonal AAT Antibody, Clone: 2B12

APG01392G 0.1ml
EUR 580.8
Description: A Monoclonal antibody against Human AAT. The antibodies are raised in Mouse and are from clone 2B12. This antibody is applicable in WB, E

Recombinant Aeromonas Hydrophila aat Protein

VAng-Lsx0907-1mgEcoli 1 mg (E. coli)
EUR 4665.6
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein.

Recombinant Aeromonas Hydrophila aat Protein

VAng-Lsx0907-500gEcoli 500 µg (E. coli)
EUR 3163.2
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein.

Recombinant Aeromonas Hydrophila aat Protein

VAng-Lsx0907-50gEcoli 50 µg (E. coli)
EUR 2151.6
Description: Aeromonas Hydrophila Leucyl/phenylalanyl-tRNA-protein transferase, recombinant protein.

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

R32565 100 ug
EUR 419

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

RQ4850 100ul
EUR 419

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3221-100UG 100 ug
EUR 499
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin.

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3221-20UG 20 ug
EUR 219
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin.

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3221SAF-100UG 100 ug
EUR 499
Description: The immunohistochemical staining of Alpha 1 Antitrypsin (AAT) is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin.

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3222-100UG 100 ug
EUR 499
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children.

Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki]

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3222-20UG 20 ug
EUR 219
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children.

Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki]

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V3222SAF-100UG 100 ug
EUR 499
Description: Alpha-1 Antitrypsin or a1-antitrypsin (A1AT) is a protease inhibitor belonging to the serpin superfamily. It is generally known as serum trypsin inhibitor. Alpha 1-antitrypsin is also referred to as alpha-1 proteinase inhibitor (A1PI) because it inhibits a wide variety of proteases. It protects tissues from enzymes of inflammatory cells, especially neutrophil elastase, and has a reference range in blood of 1.5 - 3.5 gram/liter (in US the reference range is generally expressed as mg/dL or micromoles), but the concentration can rise manyfold upon acute inflammation. In its absence (such as in alpha 1-antitrypsin deficiency), neutrophil elastase is free to break down elastin, which contributes to the elasticity of the lungs, resulting in respiratory complications such as emphysema, or COPD (chronic obstructive pulmonary disease) in adults and cirrhosis in adults or children.

Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Mutations in these areas can lead to non-functional proteins that can polymerise and accumulate in the liver (infantile hepatic cirrhosis). [Wiki]

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V8013-100UG 100 ug
EUR 499
Description: The immunohistochemical staining of AAT is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin.

Alpha 1 Antitrypsin Antibody / AAT / SERPINA1

V8013-20UG 20 ug
EUR 219
Description: The immunohistochemical staining of AAT is useful in identification of benign and malignant hepatic tumors and yolk sac carcinomas. Positive staining for AAT is also used in detection of benign and malignant lesions of histiocytic nature. This antibody is may also useful tool in the screening of patients with cryptogenic cirrhosis or other forms of liver disease with fibrosis of uncertain origin.